| Product Code: ETC13340852 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe mRNA Therapeutics Contract Development Manufacturing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Europe mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Europe mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Europe mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Europe mRNA Therapeutics Contract Development Manufacturing Market, 2021 - 2031 |
6.1 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Process Development, 2021 - 2031 |
6.1.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Analytical Testing, 2021 - 2031 |
6.1.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Manufacturing, 2021 - 2031 |
6.1.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Formulation Development, 2020 - 2028 |
6.1.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Regulatory Support, 2020 - 2028 |
6.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Therapeutics, 2021 - 2031 |
6.2.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031 |
6.2.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Personalized Medicine, 2021 - 2031 |
6.2.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Protein Replacement Therapy, 2020 - 2028 |
6.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Cancer Treatment, 2021 - 2031 |
6.3.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Rare Diseases, 2021 - 2031 |
6.3.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.3.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Autoimmune Diseases, 2021 - 2031 |
6.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.4.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Contract Manufacturing Organizations, 2020 - 2028 |
6.4.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Clinical Research Organizations, 2020 - 2028 |
6.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Lipid Nanoparticles, 2020 - 2028 |
6.5.3 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By In Vitro Transcription, 2020 - 2028 |
6.5.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Encapsulation Methods, 2020 - 2028 |
6.5.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By CRISPR Technology, 2020 - 2028 |
6.5.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By AI-Based Quality Control, 2020 - 2028 |
7 Europe mRNA Therapeutics Contract Development Manufacturing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Germany mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 France mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.4 Poland mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.5 Spain mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.6 Rest of Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United Kingdom (UK) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Germany mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 France mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.4 Poland mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.5 Spain mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.6 Rest of Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United Kingdom (UK) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Germany mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 France mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.4 Poland mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.5 Spain mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.6 Rest of Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United Kingdom (UK) mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Germany mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 France mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.4 Poland mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.5 Spain mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.6 Rest of Europe mRNA Therapeutics Contract Development Manufacturing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Europe mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
9 Europe mRNA Therapeutics Contract Development Manufacturing Market - Export/Import By Countries Assessment |
10 Europe mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
10.1 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 Europe mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Europe mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
11.1 Europe mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2022 |
11.2 Europe mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here